לונג
Nano Strong Breakout + MACD Bullish Divergence

NANOBTC (Nano) was one of the first ones to move after Dogecoin, Siacoin, and DigiByte... We have a strong breakout yesterday.
Even though we are witnessing a retrace, prices closed above EMA50 and the growth can resume in just a few days.
Strong bullish divergence with the MACD:
The RSI is above 50.
The highest trading volume yesterday since July.
There is potential for Nano to print additional growth.
Remember, a plan/strategy is necessary before jumping into any pair. It is wise and a good move that can improve your success while trading.
Namaste.
Even though we are witnessing a retrace, prices closed above EMA50 and the growth can resume in just a few days.
Strong bullish divergence with the MACD:
The RSI is above 50.
The highest trading volume yesterday since July.
There is potential for Nano to print additional growth.
Remember, a plan/strategy is necessary before jumping into any pair. It is wise and a good move that can improve your success while trading.
Namaste.
הערה
Up to 195% since sharing... Enjoy the profits.🚨 Get the FULL (6-in-1) PREMIUM PACKAGE
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
פרסומים קשורים
כתב ויתור
המידע והפרסומים אינם מיועדים להיות, ואינם מהווים, ייעוץ או המלצה פיננסית, השקעתית, מסחרית או מכל סוג אחר המסופקת או מאושרת על ידי TradingView. קרא עוד ב־תנאי השימוש.
🚨 Get the FULL (6-in-1) PREMIUM PACKAGE
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
lamatrades.com —Since 2017
🚨 TOP Results: ZEC +2736% · ETH +2150%, CRO +1272%, AAVE +1134%, DOGS +868%, SOL +861%, XRP +749%, BTC +580%
More 👉 t.me/masteranandatrades/6681
פרסומים קשורים
כתב ויתור
המידע והפרסומים אינם מיועדים להיות, ואינם מהווים, ייעוץ או המלצה פיננסית, השקעתית, מסחרית או מכל סוג אחר המסופקת או מאושרת על ידי TradingView. קרא עוד ב־תנאי השימוש.